Germany was one of the first European countries to legalise medical cannabis and is a huge potential market for non-medical CBD, given its population and the range of products already available.
Industrial hemp may be grown under strict conditions if notified to the federal agricultural agency; CBD may be extracted from both home-grown and imported industrial hemp plants, as long as the THC content is less than 0.2%.
Dried flowers are likely to be prohibited and a number of sellers have been prosecuted under existing narcotics legislation.
CBD oils and other edible products are subject to guidance from the German Federal Institute for Drugs and Medical Devices (BfArM), which effectively means a policy of zero THC for edibles.
Topical and e-liquid products containing CBD are permitted if sourced from compliant industrial hemp.
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sectors, with a focus on non-US markets. Most content is available to subscribers only.